ENSG demonstrated strong operational expansion with a 14% increase in facilities (327 to 373) while achieving robust financial growth across all key metrics, led by a 62.5% surge in operating cash flow.
The company's significant facility expansion coupled with strong financial performance suggests successful execution of a growth strategy in the healthcare services sector. The increase in facilities from 327 to 373 represents meaningful scale expansion, while the substantial improvement in cash flow generation indicates operational efficiency gains that should support continued investment and shareholder returns.
ENSG delivered strong across-the-board financial growth with revenue increasing 18.7% to $5.1B and operating cash flow surging 62.5% to $564.3M, indicating improved operational efficiency. The balance sheet expanded proportionally with total assets growing 17% to $5.5B and stockholders' equity increasing 21.5% to $2.2B, while liabilities grew at a slower 14.1% pace. The financial profile reflects a healthy, expanding business with strong cash generation capabilities that exceeded revenue growth, suggesting improved margins and working capital management.
Operating cash flow surged 62.5% — exceptional cash generation, highest quality earnings signal.
Capital expenditure jumped 30.2% — major investment cycle underway; assess returns on deployment.
Equity base grew 21.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current liabilities rose 20.3% — increased short-term obligations, watch current ratio.
Revenue growing 18.7% — solid top-line momentum, watch margins for quality of growth.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Asset base grew 17% — expansion through organic growth, acquisitions, or capital deployment.
Net income grew 15.4% — bottom-line growth signals improving overall business health.
Liabilities increased 14.1% — monitor debt-to-equity ratio and interest coverage.
Receivables grew 11.8% — monitor days sales outstanding for collection efficiency.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →